| [공지] |
2025년 학회 및 전시정보  |
관리자 |
2025.01.02 |
837 |
| 49 |
[Citation] Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis |
관리자 |
2025.11.26 |
154 |
| 48 |
[논문] Developability considerations for bispecific and multispecific antibodies |
관리자 |
2025.11.18 |
98 |
| 47 |
[Citation] Endogenous DEL-1 restrains melanoma lung metastasis by limiting |
관리자 |
2025.11.11 |
157 |
| 46 |
[논문] Bispecific antibodies: advancing precision oncology |
관리자 |
2025.11.03 |
193 |
| 45 |
[Citation] Colony-stimulating factor 3 |
관리자 |
2025.10.17 |
239 |
| 44 |
[논문] Quantifying antibody binding techniques and therapeutic implications |
관리자 |
2025.08.18 |
473 |
| 43 |
[논문] T cell- specific non- viral DNA delivery and in vivo CAR- T generation using targeted lipid nanoparticles |
관리자 |
2025.08.18 |
436 |
| 42 |
Discovery Antibody Screening Services |
관리자 |
2025.07.23 |
378 |
| 41 |
[논문] Translational minimal physiologically based pharmacokinetic model for transferrin receptor-mediated brain delivery |
관리자 |
2025.06.30 |
370 |
| 40 |
[논문] Leveraging neonatal Fc receptor (FcRn) to enhanceantibodytransportacrosstheblood brain barrier |
관리자 |
2025.06.30 |
328 |
| 39 |
Ymax®-NANO : A Single Domain Antibody Library |
관리자 |
2025.06.30 |
241 |
| 38 |
[논문] TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer |
관리자 |
2025.06.01 |
332 |
| 37 |
[논문] Antibodies to watch in 2025 |
관리자 |
2025.02.05 |
1,011 |
| 36 |
[서비스 브로셔] Human Nanobody Screening |
관리자 |
2025.01.02 |
712 |
| 35 |
[논문] Facilitating high throughput bispecific antibody production and potential applications within ... |
관리자 |
2024.11.29 |
578 |
| 34 |
[논문] A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage... |
관리자 |
2024.11.29 |
524 |
| 33 |
[전시/학회] Cytokines 2024 & KAI 2024 |
관리자 |
2024.09.30 |
574 |
| 32 |
[서비스 브로셔] Recombinant Protein Production |
관리자 |
2024.09.10 |
681 |
| 31 |
[서비스 브로셔] Affinity Maturation |
관리자 |
2024.08.06 |
682 |
| 30 |
[서비스 브로셔] Antibody Humanization |
관리자 |
2024.08.06 |
552 |
